Xlife Sciences AG (XLS DE): Breakthrough in Drug Development
- Written by Reporters
First available holistic medical drug to treat Covid-19 and flu viruses
ZURICH, SWITZERLAND - EQS Newswire - 10 June 2021 - As a project company of Xlife Sciences AG (XLS DE), inflamed pharma GmbH has developed a revolutionary and holistic therapeutic approach to treat both SARS-CoV-2 and flu viruses. The patented active substance...
Read more: Xlife Sciences AG (XLS DE): Breakthrough in Drug Development

